ArticleJournal of hepatocellular carcinoma2025

A Multicenter Retrospective Study: Impact of First-Line Treatment Strategies on second-Line Efficacy and Safety of Regorafenib with or Without PD-1 Inhibitors in Unresectable Hepatocellular Carcinoma.

Weihong Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.